Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Trinitan Metals and Minerals Tbk. (PURE) vs Organon Pharma Indonesia Tbk. (SCPI)

Trinitan Metals and Minerals Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Trinitan Metals and Minerals Tbk. dan Organon Pharma Indonesia Tbk.: Trinitan Metals and Minerals Tbk. diperdagangkan di Rp51 (kapitalisasi pasar 70,13 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

PURESCPI
Kapitalisasi Pasar
70,13 M104,4 M

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

PURE
Lihat detail
SCPI
Lihat detail

Tentang Trinitan Metals and Minerals Tbk.

PT Trinitan Metals and Minerals Tbk (the Entity) was established based on Notarial Deed No. 14, dated June 9, 2009, of Petrus Suandi Halim, S.H., notary in Jakarta. The Entity started its commercial operations in 2011. The Entity belong to group of companies owned by Trinitan Group. The Entity's parent entity is PT Trinitan Resourcetama Indonesia.

Selengkapnya di halaman PURE

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI